Tumor-Infiltrating Lymphocytes Contain Higher Numbers of Type 1 Cytokine Expressors and DR+ T Cells Compared with Lymphocytes from Tumor Draining Lymph Nodes and Peripheral Blood in Patients with Cancer of the Uterine Cervix
- 30 June 2001
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 81 (3), 424-432
- https://doi.org/10.1006/gyno.2001.6200
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Lymph node metastasesCancer, 2000
- The host—tumor immune conflict: from immunosuppression to resistance and destructionImmunology Today, 1997
- Reactivation of murine tumour-infiltrating lymphocytes with solid-phase anti-CD3 antibody: in vitro cytokine production is associated with in vivo efficacySurgical Oncology, 1994
- Lymphocyte responses and cytokinesCell, 1994
- Development of an immunological staging system to prognosticate disease course in malignant cervical neoplasiaGynecologic Oncology, 1990
- Rapidly progressing cervical cancer in a patient with human immunodeficiency virus infectionGynecologic Oncology, 1990
- Immune function in malignant cervical neoplasia: A multiparameter analysisGynecologic Oncology, 1988
- Role of Cell‐Mediated Immunity in Spontaneous Regression of Plane WartsInternational Journal of Dermatology, 1988
- Behavior of Mild Cervical Dysplasia During Long-Term Follow-upObstetrics & Gynecology, 1986
- Differential expression of T cell differentiation antigens and major histocompatibility antigens on activated T cells during the cell cycleEuropean Journal of Immunology, 1986